About Augurex
Augurex is a company based in Vancouver (Canada) founded in 2006. Augurex has raised $978.2 thousand across 3 funding rounds from investors including WUTIF. Augurex offers products and services including Biomarker Tests and Diagnostic Solutions. Augurex operates in a competitive market with competitors including Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and BillionToOne, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Augurex Life Sciences Corp.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$978.2 K (USD)
in 3 rounds
-
Latest Funding Round
$25.2 K (USD), Seed
Feb 01, 2011
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Augurex
Augurex offers a comprehensive portfolio of products and services, including Biomarker Tests and Diagnostic Solutions.
Tests for early detection and management of rheumatoid arthritis.
Tools for diagnosing and monitoring axial spondyloarthritis conditions.
People of Augurex
Unlock access to complete
Unlock access to complete
Funding Insights of Augurex
Augurex has successfully raised a total of $978.2K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $25.2 thousand completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Augurex
Augurex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include WUTIF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage technology startups in British Columbia are funded by WUTIF.
|
Locked | Locked | Locked |
Investor details for Augurex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Augurex
Investment portfolio details for Augurex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Augurex
Detailed financials for Augurex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Augurex Comparisons
Peer comparison for Augurex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Augurex
Augurex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Thrive Earlier Detection, Delfi Diagnostics and BillionToOne, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Circulating tumor DNA is screened for early cancer detection.
|
|
| Locked | Locked | Locked |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
|
| Locked | Locked | Locked |
Provider of DNA sequencing for cancer detection
|
|
| Locked | Locked | Locked |
Provider of cell-free cancer liquid biopsy test
|
|
| Locked | Locked | Locked |
Non-invasive blood tests for prenatal fetal health predictions are offered.
|
Detailed competitors of Augurex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Augurex
Complete news archive for Augurex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Augurex
Augurex was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Augurex is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Augurex is a funded company, having raised a total of $978.2K across 3 funding rounds to date.
Augurex was founded in 2006 in Vancouver, Canada, within the biotechnology sector focused on medical diagnostics. Tests are developed to identify autoimmune and chronic conditions, with operations centered on protein biomarker analysis. The flagship product, JOINTstat, quantifies serum levels of 14-3-3η protein in patients suspected of rheumatoid arthritis. Elevated levels are linked to increased disease risk, supporting clinical decisions on joint monitoring frequency.
Augurex's top competitors include Guardant Health, GRAIL and BillionToOne.
Augurex offers Biomarker Tests and Diagnostic Solutions.
Augurex has 1 investor. Key investors include WUTIF.